(Mark One) | |
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Not Applicable | |||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||
300 East Lombard Street, Suite 1710 | |||||
(Zip Code) | |||||
(Address of principal executive office (US)) | |||||
(Registrant's telephone number, including area code) | |||||
Securities registered pursuant to section 12(b) of the Act | |||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | |||
x | Accelerated filer | ☐ | ||
Non-accelerated filer | ☐ | Smaller reporting company | ||
Emerging growth company |
Page | ||
Item 1. | ||
Item 1A. | ||
Item 1B. | ||
Item 1C. | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Item 5. | ||
Item 6. | ||
Item 7. | ||
Item 7A. | ||
Item 8. | ||
Item 9. | ||
Item 9A. | ||
Item 9B. | ||
Item 9C. | ||
Item 10. | ||
Item 11. | ||
Item 12. | ||
Item 13. | ||
Item 14. | ||
Item 15. | ||
Item 16. | ||
Location | Country | Owned/Leased | ||
Packaging & Automotive Rolled Products | ||||
Biesheim, Neuf-Brisach | France | Owned | ||
Singen | Germany | Owned | ||
Muscle Shoals, AL | United States | Owned | ||
Bowling Green, KY | United States | Owned | ||
Aerospace & Transportation | ||||
Issoire | France | Owned | ||
Montreuil-Juigné | France | Owned | ||
Ravenswood, WV | United States | Owned | ||
Steg | Switzerland | Owned | ||
Sierre | Switzerland | Owned | ||
Automotive Structures & Industry | ||||
Lakeshore, Ontario (JV) (1) | Canada | Leased | ||
Changchun, Jilin Province (JV) (2) | China | Leased | ||
Nanjing | China | Leased | ||
Děčín | Czech Republic | Owned(3) | ||
Nuits-Saint-Georges | France | Owned | ||
Neckarsulm | Germany | Owned | ||
Gottmadingen | Germany | Leased | ||
Singen | Germany | Owned(3) | ||
San Luis Potosi | Mexico | Leased | ||
Levice | Slovakia | Owned/Leased | ||
Zilina | Slovakia | Leased | ||
Vigo | Spain | Leased | ||
Chippis | Switzerland | Owned | ||
Sierre | Switzerland | Owned | ||
Van Buren, MI | United States | Leased | ||
White, GA | United States | Leased |
Period | Total number of shares purchased | Average price paid per share | Total number of shares purchased as part of publicly announced programs | Maximum approximate dollar value that may yet be purchased under the program | ||||
October 1 - October 31, 2024 | — | 0 | — | 239,642,036 | ||||
November 1 - November 30, 2024 | 1,557,520 | 11.86 | 1,557,520 | 221,217,362 | ||||
December 1 - December 31, 2024 | — | 0 | — | 221,217,362 | ||||
Total | 1,557,520 | 1,557,520 | 221,217,362 |
Year ended December 31, 2024 | ||||
(as a % of total) | Revenue | Segment Adjusted EBITDA | ||
A&T | 25% | 50% | ||
P&ARP | 57% | 43% | ||
AS&I | 20% | 13% | ||
Holdings and Corporate | —% | (6)% | ||
Total | 100% | 100% |
Year ended December 31, | Percent changes | |||||||||
(U.S. dollars per ton) | 2024 | 2023 | 2022 | 2024 vs 2023 | 2023 vs 2022 | |||||
Average LME transaction price | 2,419 | 2,250 | 2,708 | 8% | (17)% | |||||
Average Midwest premium | 432 | 510 | 658 | (15)% | (22)% | |||||
Average all-in aluminum price U.S. | 2,851 | 2,760 | 3,366 | 3% | (18)% | |||||
Average LME transaction price | 2,419 | 2,250 | 2,708 | 8% | (17)% | |||||
Average Rotterdam premium (ECDP) | 314 | 276 | 469 | 14% | (41)% | |||||
Average all-in aluminum price Europe | 2,733 | 2,526 | 3,177 | 8% | (20)% |
For the years ended December 31, | ||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2024 | 2023 | 2022 | |||||||||
Revenue | 7,335 | 100% | 7,826 | 100% | 8,532 | 100% | ||||||
Cost of sales (excluding depreciation and amortization) | (6,397) | 87% | (6,771) | 87% | (7,569) | 89% | ||||||
Depreciation and amortization | (304) | 4% | (300) | 4% | (290) | 3% | ||||||
Selling and administrative expenses | (313) | 4% | (317) | 4% | (284) | 3% | ||||||
Research and development expenses | (49) | 1% | (52) | 1% | (46) | 1% | ||||||
Other gains and losses - net | (26) | —% | (43) | 1% | (90) | 1% | ||||||
Finance costs - net | (111) | 2% | (111) | 1% | (103) | 1% | ||||||
Income before tax | 135 | 2% | 232 | 3% | 150 | 2% | ||||||
Income tax (expense) / benefit | (75) | 1% | (75) | 1% | 165 | 2% | ||||||
Net income | 60 | 1% | 157 | 2% | 315 | 4% | ||||||
Shipment volumes (in kt) | 1,438 | n/a | 1,492 | n/a | 1,580 | n/a |
(in millions of U.S. dollar) | Total | |
Revenue for the year ended December 31, 2023 | 7,826 | |
Volume | (382) | |
Price and product mix | (152) | |
Metal price | 132 | |
Foreign exchange and other | (89) | |
Revenue for the year ended December 31, 2024 | 7,335 |
Year ended December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
Operating income and expenses | ||||
Realized gains / (losses) on derivatives | 12 | (50) | ||
Unrealized losses on derivatives at fair value through profit and loss - net | (1) | (3) | ||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | 1 | (2) | ||
Impairment of assets | (24) | (22) | ||
Restructuring costs | (11) | — | ||
(Losses) / gains on disposal | (4) | 41 | ||
Result from the flood in Valais | 2 | — | ||
Non-operating income and expenses | ||||
Expenses on factoring arrangements | (22) | (24) | ||
Pension and other post-employment benefits | 11 | 14 | ||
Other | 10 | 3 | ||
Total other gains and losses - net | (26) | (43) |
For years ended December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
Realized (losses) / gains on foreign currency derivatives - net | (10) | 18 | ||
Realized gains / (losses) on commodities derivatives - net | 22 | (68) | ||
Realized gains / (losses) on derivatives | 12 | (50) | ||
Unrealized (losses) / gains on foreign currency derivatives - net | (20) | (14) | ||
Unrealized gains on commodities derivatives - net | 19 | 11 | ||
Unrealized losses on derivatives at fair value through profit and loss - net | (1) | (3) |
(in millions of U.S. dollar) | Total | |
Revenue for the year ended December 31, 2022 | 8,532 | |
Volume | (398) | |
Price and product mix | 647 | |
Metal price | (1,188) | |
Foreign exchange and other | 232 | |
Revenue for the year ended December 31, 2023 | 7,826 |
Year ended December 31, | ||||
(in millions of U.S. dollar) | 2023 | 2022 | ||
Operating income and expenses | ||||
Realized losses on derivatives | (50) | (8) | ||
Unrealized losses on derivatives at fair value through profit and loss - net | (3) | (48) | ||
Unrealized exchange losses from the remeasurement of monetary assets and liabilities – net | (2) | (2) | ||
Impairment of assets | (22) | (16) | ||
Restructuring costs | — | (1) | ||
Gains / (losses) on disposal | 41 | (5) | ||
Non-operating income and expenses | ||||
Expenses on factoring arrangements | (24) | (16) | ||
Pension and other post-employment benefits | 14 | 2 | ||
Other | 3 | 4 | ||
Total other gains and losses - net | (43) | (90) |
For years ended December 31, | ||||
(in millions of U.S. dollar) | 2023 | 2022 | ||
Realized gains / (losses) on foreign currency derivatives - net | 18 | (1) | ||
Realized losses on commodities derivatives - net | (68) | (7) | ||
Realized losses on derivatives | (50) | (8) | ||
Unrealized (losses) / gains on foreign currency derivatives - net | (14) | 8 | ||
Unrealized gains / (losses) on commodities derivatives - net | 11 | (56) | ||
Unrealized losses on derivatives at fair value through profit and loss - net | (3) | (48) |
For years ended December 31, | ||||||||||||
(in millions of U.S. dollars and as a % of revenue) | 2024 | 2023 | 2022 | |||||||||
A&T | 1,816 | 25% | 1,868 | 24% | 1,786 | 21% | ||||||
P&ARP | 4,196 | 57% | 4,214 | 54% | 4,900 | 57% | ||||||
AS&I | 1,432 | 20% | 1,762 | 23% | 1,955 | 23% | ||||||
Holdings and Corporate | 6 | —% | 21 | —% | — | —% | ||||||
Inter-segment eliminations | (115) | n.m | (39) | n.m | (110) | n.m | ||||||
Total revenue | 7,335 | 100% | 7,826 | 100% | 8,532 | 100% |
For years ended December 31, | |||||||||||
(in kt as a % of shipments) | 2024 | 2023 | 2022 | ||||||||
A&T | 209 | 15% | 219 | 15% | 222 | 14% | |||||
P&ARP | 1,027 | 71% | 1,030 | 69% | 1,089 | 69% | |||||
AS&I | 201 | 14% | 243 | 16% | 268 | 17% | |||||
Holdings and Corporate | — | —% | — | —% | — | —% | |||||
Total shipments | 1,438 | 100% | 1,492 | 100% | 1,580 | 100% |
For years ended December 31, | ||||||||||||
(in millions of U.S. dollar and as a % of revenue) | 2024 | 2023 | 2022 | |||||||||
A&T | 285 | 16% | 351 | 19% | 228 | 13% | ||||||
P&ARP | 242 | 6% | 305 | 7% | 328 | 7% | ||||||
AS&I | 74 | 5% | 129 | 7% | 143 | 7% | ||||||
Holdings and Corporate | (33) | n.m | (31) | n.m | (21) | n.m |
For years ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
A&T | 285 | 351 | 228 | |||
P&ARP | 242 | 305 | 328 | |||
AS&I | 74 | 129 | 143 | |||
H&C | (33) | (31) | (21) | |||
Segment Adjusted EBITDA | 568 | 754 | 678 | |||
Metal price lag (A) | 55 | (92) | (31) | |||
Depreciation and amortization | (304) | (300) | (290) | |||
Impairment of assets (B) | (24) | (22) | (16) | |||
Share based compensation costs | (25) | (22) | (18) | |||
Pension and other post-employment benefits - non operating gains | 11 | 14 | 2 | |||
Restructuring costs (C) | (11) | — | (1) | |||
Unrealized losses on derivatives | (1) | (3) | (48) | |||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | 1 | (2) | (2) | |||
(Losses) / gains on disposal (D) | (4) | 41 | (5) | |||
Other (E) | 2 | (1) | — | |||
Expenses on factoring arrangements | (22) | (24) | (16) | |||
Finance costs - net | (111) | (111) | (103) | |||
Income before tax | 135 | 232 | 150 | |||
Income tax (expense) / benefit | (75) | (75) | 165 | |||
Net income | 60 | 157 | 315 |
(in millions of U.S. dollar) | A&T | P&ARP | AS&I | |||
Segment Adjusted EBITDA for the year ended December 31, 2022 | 228 | 328 | 143 | |||
Volume | (9) | (40) | (28) | |||
Price and product mix | 243 | 168 | 66 | |||
Costs | (118) | (152) | (53) | |||
Foreign exchange and other | 7 | 1 | 1 | |||
Segment Adjusted EBITDA for the year ended December 31, 2023 | 351 | 305 | 129 | |||
Volume | (19) | — | (22) | |||
Price and product mix | (48) | (18) | (25) | |||
Costs | 11 | (46) | 20 | |||
Flood impact | (13) | — | (20) | |||
Foreign exchange and other | 3 | 1 | (8) | |||
Segment Adjusted EBITDA for the year ended December 31, 2024 | 285 | 242 | 74 |
For years ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Net Cash Flows from / (used in) | ||||||
Operating activities | 301 | 432 | 365 | |||
Investing activities | (313) | (216) | (196) | |||
Financing activities | (61) | (177) | (150) | |||
Net (decrease) / increase in cash and cash equivalents, excluding the effect of exchange rate changes | (73) | 39 | 19 |
For years ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Net income | 60 | 157 | 315 | |||
Income tax expense | 75 | 75 | (165) | |||
Finance costs - net | 111 | 111 | 103 | |||
Expenses on factoring arrangements | 22 | 24 | 16 | |||
Depreciation and amortization | 304 | 300 | 290 | |||
Impairment of assets (B) | 24 | 22 | 16 | |||
Restructuring costs (C) | 11 | — | 1 | |||
Unrealized losses / (gains) on derivatives | 1 | 3 | 48 | |||
Unrealized exchange losses / (gains) from the remeasurement of monetary assets and liabilities – net | (1) | 2 | 2 | |||
Pension and other post-employment benefits - non operating gains | (11) | (14) | (2) | |||
Share based compensation costs | 25 | 22 | 18 | |||
Losses / (gains) on disposal (D) | 4 | (41) | 5 | |||
Other (E) | (2) | 1 | — | |||
Adjusted EBITDA1 | 623 | 662 | 647 | |||
of which Metal price lag (A) | 55 | (92) | (31) |
(in millions of U.S. dollar) | Effect on income before tax | Effect on pretax equity | ||
Trade receivables | 3 | — | ||
Trade payables | (32) | — | ||
Derivatives on commercial transactions (A) | (36) | (42) | ||
Net commercial transaction exposure | (65) | (42) | ||
Cash in Bank and intercompany loans | 109 | — | ||
Borrowings | (131) | — | ||
Derivatives on financing transactions | 22 | — | ||
Net financing transaction exposure | — | — | ||
Total | (65) | (42) |
(in millions of U.S. dollar) | Effect on net income | Effect on equity | ||
10% strengthening U.S. dollar versus euro | (7) | (58) |
Year ended December 31, | ||||||||
(in millions of U.S. dollar) | Notes | 2024 | 2023 | 2022 | ||||
Revenue | 2 | |||||||
Cost of sales (excluding depreciation and amortization) | ( | ( | ( | |||||
Depreciation and amortization | ( | ( | ( | |||||
Selling and administrative expenses | ( | ( | ( | |||||
Research and development expenses | ( | ( | ( | |||||
Other gains and losses - net | 5 | ( | ( | ( | ||||
Finance costs - net | 6 | ( | ( | ( | ||||
Income before tax | ||||||||
Income tax (expense) / benefit | 7 | ( | ( | |||||
Net income | ||||||||
Net income attributable to: | ||||||||
Equity holders of Constellium | ||||||||
Non-controlling interests | ||||||||
Net income |
Earnings per share attributable to the equity holders of Constellium (in dollars) | Notes | 2024 | 2023 | 2022 | ||||
Basic | 8 | |||||||
Diluted | 8 |
Year ended December 31, | ||||||||
(in millions of U.S. dollar) | Notes | 2024 | 2023 | 2022 | ||||
Net income | ||||||||
Other comprehensive (loss) / income | ||||||||
Net change in post-employment benefit obligations | ( | |||||||
Income tax on net change in post-employment benefit obligations | ( | ( | ||||||
Cash flow hedges | 16 | ( | ( | |||||
Income tax on cash flow hedges | ( | |||||||
Currency translation differences | ( | ( | ||||||
Other comprehensive (loss) / income | ( | ( | ||||||
Total comprehensive income | ||||||||
Attributable to : | ||||||||
Equity holders of Constellium | ||||||||
Non-controlling interests | ||||||||
Total comprehensive income | ||||||||
At December 31, | ||||||
(in millions of U.S. dollar) except share data | Notes | 2024 | 2023 | |||
Assets | ||||||
Current assets | ||||||
Cash and cash equivalents | ||||||
Trade receivables and other, net | 9 | |||||
Inventories | 10 | |||||
Fair value of derivatives instruments and other financial assets | 16 | |||||
Total current assets | ||||||
Non-current assets | ||||||
Property, plant and equipment, net | 11 | |||||
Goodwill | 13 | |||||
Intangible assets, net | 13 | |||||
Deferred tax assets | 7 | |||||
Trade receivables and other, net | 9 | |||||
Fair value of derivatives instruments | 16 | |||||
Total non-current assets | ||||||
Total assets | ||||||
Liabilities | ||||||
Current liabilities | ||||||
Trade payables and other | 14 | |||||
Short-term debt | 15 | |||||
Fair value of derivatives instruments | 16 | |||||
Income tax payable | ||||||
Pension and other benefit obligations | 17 | |||||
Provisions | 18 | |||||
Total current liabilities | ||||||
Non-current liabilities | ||||||
Trade payables and other | 14 | |||||
Long-term debt | 15 | |||||
Fair value of derivatives instruments | 16 | |||||
Pension and other benefit obligations | 17 | |||||
Provisions | 18 | |||||
Deferred tax liabilities | 7 | |||||
Total non-current liabilities | ||||||
Total liabilities | ||||||
Commitments and contingencies | 21 | |||||
Shareholder's equity | ||||||
Ordinary shares, par value € 2024 and 2023 | 19 | |||||
Additional paid in capital | 19 | |||||
Accumulated other comprehensive income | 20 | ( | ||||
Retained earnings and other reserves | ||||||
Equity attributable to equity holders of Constellium | ||||||
Non-controlling interests | ||||||
Total equity | ||||||
Total equity and liabilities |
(in millions of U.S. dollar) | Ordinary shares | Additional paid in capital | Treasury shares | Accumulated other comprehensive (loss) / income | Other reserves | Retained earnings | Total | Non- controlling interests | Total equity | |||||||||
At January 1, 2024 | ||||||||||||||||||
Net income | — | — | — | — | — | |||||||||||||
Other comprehensive income / (loss) | — | — | — | ( | — | — | ( | ( | ( | |||||||||
Total comprehensive income / (loss) | — | — | — | ( | — | |||||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||||
Repurchase of ordinary shares | — | — | ( | — | — | — | ( | — | ( | |||||||||
Allocation of treasury shares to share-based compensation plan vested | — | — | — | — | ( | — | ||||||||||||
Transactions with non- controlling interests | — | — | — | — | — | — | — | ( | ( | |||||||||
At December 31, 2024 | ( | ( |
(in millions of U.S. dollar) | Ordinary shares | Additional paid in capital | Treasury shares | Accumulated other comprehensive income / (loss) | Other reserves | Retained earnings | Total | Non- controlling interests | Total equity | |||||||||
At January 1, 2023 | ( | |||||||||||||||||
Net income | — | — | — | — | — | |||||||||||||
Other comprehensive income / (loss) | — | — | — | ( | — | — | ( | — | ( | |||||||||
Total comprehensive income / (loss) | — | — | — | ( | — | |||||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||||
Transactions with non-controlling interests | — | — | — | — | — | — | — | ( | ( | |||||||||
At December 31, 2023 |
(in millions of U.S. dollar) | Ordinary shares | Additional paid in capital | Treasury shares | Accumulated other comprehensive (loss) / income | Other reserves | Retained earnings | Total | Non- controlling interests | Total equity | |||||||||
At January 1, 2022 | ( | ( | ||||||||||||||||
Net income | — | — | — | — | — | |||||||||||||
Other comprehensive income / (loss) | — | — | — | — | — | ( | ||||||||||||
Total comprehensive income / (loss) | — | — | — | — | ||||||||||||||
Share-based compensation | — | — | — | — | — | — | ||||||||||||
Transactions with non-controlling interests | — | — | — | — | — | — | — | ( | ( | |||||||||
At December 31, 2022 | ( | |||||||||||||||||
Year ended December 31, | ||||||||
(in millions of U.S. dollar) | Notes | 2024 | 2023 | 2022 | ||||
Net income | ||||||||
Adjustments | ||||||||
Depreciation and amortization | 11, 13 | |||||||
Impairment of assets | 5 | |||||||
Pension and other long-term benefits | 17 | |||||||
Finance costs - net | 6 | |||||||
Income tax expense / (benefit) | 7 | ( | ||||||
Unrealized losses on derivatives - net and from remeasurement of monetary assets and liabilities - net | ||||||||
Losses / (gains) on disposal | 5 | ( | ||||||
Other - net | ||||||||
Changes in working capital | ||||||||
Inventories | ( | ( | ||||||
Trade receivables | ( | ( | ||||||
Trade payables | ( | ( | ||||||
Other | ( | ( | ( | |||||
Change in provisions | ( | ( | ||||||
Pension and other long-term benefits paid | 17 | ( | ( | ( | ||||
Interest paid | ( | ( | ( | |||||
Income tax paid | ( | ( | ( | |||||
Net cash flows from operating activities | ||||||||
Purchases of property, plant and equipment | 3 | ( | ( | ( | ||||
Property, plant and equipment inflows | 3 | |||||||
Collection of deferred purchase price receivable | 9 | |||||||
Acquisition of subsidiaries net of cash acquired | 23 | |||||||
Proceeds from disposals, net of cash | 23 | |||||||
Other investing activities | ( | |||||||
Net cash flows used in investing activities | ( | ( | ( | |||||
Repurchase of ordinary shares | ( | |||||||
Proceeds from issuance of long-term debt | ||||||||
Repayments of long-term debt | ( | ( | ( | |||||
Net change in revolving credit facilities and short-term debt | ( | |||||||
Finance lease repayments | ( | ( | ( | |||||
Payment of financing costs and redemption fees | ( | ( | ||||||
Transactions with non-controlling interests | ( | ( | ( | |||||
Other financing activities | ( | ( | ||||||
Net cash flows used in financing activities | ( | ( | ( | |||||
Net (decrease) / increase in cash and cash equivalents | ( | |||||||
Cash and cash equivalents - beginning of year | ||||||||
Transfer of cash and cash equivalents from / (to) assets classified as held for sale | ( | |||||||
Effect of exchange rate changes on cash and cash equivalents | ( | ( | ||||||
Cash and cash equivalents - end of year |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Aerospace rolled products | ||||||
Transportation, industry, defense and other rolled products | ||||||
Packaging rolled products | ||||||
Automotive rolled products | ||||||
Specialty and other thin-rolled products | ||||||
Automotive extruded products | ||||||
Other extruded products | ||||||
Other | ||||||
Total revenue by product line |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
United States | ||||||
Germany | ||||||
France | ||||||
Spain | ||||||
United Kingdom | ||||||
Poland | ||||||
Czech Republic | ||||||
All other | ||||||
Total revenue by destination of shipment |
2024 | 2023 | 2022 | |||||||||||||
(in millions of U.S. dollar) | A&T | P&ARP | AS&I | H&C | A&T | P&ARP | AS&I | H&C | A&T | P&ARP | AS&I | H&C | |||
Segment revenue | |||||||||||||||
Inter-segment elimination | ( | ( | ( | ( | ( | ( | ( | ( | ( | ||||||
External revenue | |||||||||||||||
Cost of metal | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |||||
Production costs | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |||
Other segment expenses (A) | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | ( | |||
Segment adjusted EBITDA | ( | ( | ( |
Year ended December 31, | ||||||||
(in millions of U.S. dollar) | Notes | 2024 | 2023 | 2022 | ||||
A&T | ||||||||
P&ARP | ||||||||
AS&I | ||||||||
H&C | ( | ( | ( | |||||
Segment Adjusted EBITDA | ||||||||
Metal price lag (A) | ( | ( | ||||||
Depreciation and amortization | 11, 13 | ( | ( | ( | ||||
Impairment of assets (B) | 5 | ( | ( | ( | ||||
Share based compensation costs | 22 | ( | ( | ( | ||||
Pension and other post-employment benefits - non operating gains | 5, 17 | |||||||
Restructuring costs (C) | 5 | ( | ( | |||||
Unrealized losses on derivatives | 5 | ( | ( | ( | ||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | 5 | ( | ( | |||||
(Losses) / gains on disposal (D) | 5 | ( | ( | |||||
Other (E) | ( | |||||||
Expenses on factoring arrangements | 9 | ( | ( | ( | ||||
Finance costs - net | 6 | ( | ( | ( | ||||
Income before tax | ||||||||
Income tax (expense) / benefit | 7 | ( | ( | |||||
Net income |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
A&T | ( | ( | ( | |||
P&ARP | ( | ( | ( | |||
AS&I | ( | ( | ( | |||
H&C | ( | ( | ( | |||
Total capital expenditures (A) | ( | ( | ( |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
A&T | ( | ( | ( | |||
P&ARP | ( | ( | ( | |||
AS&I | ( | ( | ( | |||
H&C | ( | ( | ( | |||
Total depreciation, amortization and impairment expense | ( | ( | ( |
At December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
A&T | ||||
P&ARP | ||||
AS&I | ||||
H&C | ||||
Segment assets | ||||
Deferred income tax assets | ||||
Cash and cash equivalents | ||||
Fair value of derivatives instruments and other financial assets | ||||
Total assets |
At December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
United States | ||||
France | ||||
Germany | ||||
Czech Republic | ||||
Other | ||||
Total property plant and equipment |
Year ended December 31, | ||||||||
(in millions of U.S. dollar) | Notes | 2024 | 2023 | 2022 | ||||
Operating income and expenses | ||||||||
Realized gains / (losses) on derivatives (A) | ( | ( | ||||||
Unrealized losses on derivatives at fair value through profit and loss - net (A) | ( | ( | ( | |||||
Unrealized exchange gains / (losses) from the remeasurement of monetary assets and liabilities – net | ( | ( | ||||||
Impairment of assets (B) | ( | ( | ( | |||||
Restructuring costs (C) | ( | ( | ||||||
(Losses) / gains on disposal (D) | ( | ( | ||||||
Result from the flood in Valais (E) | ||||||||
Non-operating income and expenses | ||||||||
Expenses on factoring arrangements | 9 | ( | ( | ( | ||||
Pension and other post-employment benefits | 17 | |||||||
Other (F) | ||||||||
Total other gains and losses - net | ( | ( | ( |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Interest expense on borrowings (A) | ( | ( | ( | |||
Interest expense on finance leases | ( | ( | ( | |||
Interest cost on pension and other long-term benefits | ( | ( | ( | |||
Net loss on settlement of debt (B) | ( | |||||
Realized and unrealized gains on debt derivatives at fair value (C) | ||||||
Realized and unrealized exchange (losses) / gains on financing activities - net (C) | ( | ( | ||||
Other finance expenses | ( | ( | ( | |||
Capitalized borrowing costs (D) | ||||||
Finance expenses | ( | ( | ( | |||
Finance costs - net | ( | ( | ( |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Domestic (France) | ||||||
Foreign | ( | |||||
Income before tax |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Income before tax | ||||||
Statutory tax rate applicable to the parent company | ||||||
Income tax expense calculated at statutory tax rate | ( | ( | ( | |||
Effect of foreign tax rate (A) | ( | |||||
Investment in subsidiaries (B) | ( | ( | ||||
Changes in valuation allowance (C) | ( | ( | ||||
Change in tax laws and rates (D) | ( | |||||
Prior year adjustments | ( | ( | ||||
BEAT Tax | ( | ( | ( | |||
Other | ( | ( | ( | |||
Income tax (expense) / benefit | ( | ( | ||||
Effective income tax rate | ( |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Domestic (France) | ( | ( | ( | |||
Foreign | ( | ( | ( | |||
Current tax expense | ( | ( | ( | |||
Domestic (France) | ( | ( | ||||
Foreign | ( | ( | ||||
Deferred tax (expense) / benefit | ( | ( | ||||
Income tax (expense) / benefit | ( | ( |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Unrecognized tax benefits at January 1, (A) | ||||||
Additions for tax position of the current year | ||||||
Additions for tax position of prior years | ||||||
Reductions for tax positions of prior years (B) | ( | |||||
Settlements with tax authorities | ( | ( | ||||
Reductions for expiration of statute of limitations | ( | ( | ||||
Unrecognized tax benefits at December 31, (A) |
At December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
Net deferred income tax assets | ||||
Net deferred income tax liabilities | ( | ( | ||
Net deferred taxes |
At December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
Deferred income tax assets | ||||
Tax losses carried forward | ||||
Long term assets | ||||
Pensions | ||||
Derivative valuation | ||||
Interest carried forward | ||||
Other (A) | ||||
Total deferred income tax assets | ||||
Less: valuation allowance (B) | ( | ( | ||
Deferred income tax assets, net of valuation allowance | ||||
Deferred income tax liabilities | ||||
Long-term assets | ( | ( | ||
Inventories | ( | ( | ||
Other | ||||
Deferred income tax liabilities | ( | ( |
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
At January 1, | ||||||
Deduction | ( | ( | ( | |||
Addition | ||||||
At December 31, | ||||||
At December 31, 2024 | ||||||||
(in millions of U.S. dollar) | Tax Losses Carried Forward | Valuation Allowance | Carryforward Period | Earliest Year of Expiration | ||||
Net operating loss | ||||||||
United States | Indefinite | — | ||||||
United States | 20 years | 2032 | ||||||
France | ( | Indefinite | — | |||||
Germany | ( | Indefinite | — | |||||
Switzerland | ( | 7 years | 2028 | |||||
China | ( | 5 years | 2025 | |||||
Other | ( | > 5 years or indefinite | 2027 | |||||
Total | ( |
Year ended December 31, | ||||||
(in millions of US Dollars except share and per share amounts ) | 2024 | 2023 | 2022 | |||
Numerator: | ||||||
Net income attributable to equity holders of Constellium | ||||||
Denominator: | ||||||
Basic - weighted-average ordinary shares outstanding | ||||||
Dilutive effect of non-vested restricted stock units and performance- based restricted stock units | ||||||
Diluted - weighted-average ordinary shares, of restricted stock units and performance-based restricted stock units | ||||||
Basic earnings per share | $ | $ | $ | |||
Diluted earnings per share | $ | $ | $ |
At December 31, | ||||||||
2024 | 2023 | |||||||
(in millions of U.S. dollar) | Non-current | Current | Non-current | Current | ||||
Trade receivables - gross | ||||||||
Allowance for doubtful receivables | ( | ( | ||||||
Total trade receivables - net | ||||||||
Income tax receivables | ||||||||
Other tax receivables | ||||||||
Contract assets | ||||||||
Other | ||||||||
Total other receivables | ||||||||
Total trade receivables and other |
At December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
Finished goods | ||||
Work in progress | ||||
Raw materials | ||||
Stores and supplies | ||||
Total inventories |
(in millions of U.S. dollar) | Land and Property Rights | Buildings | Machinery and Equipment | Construction Work in Progress | Other | Property, Plant and Equipment | ||||||
At December 31, 2024 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated depreciation | ( | ( | ( | ( | ( | |||||||
Net balance at December 31, 2024 | ||||||||||||
At December 31, 2023 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated depreciation | ( | ( | ( | ( | ( | |||||||
Net balance at December 31, 2023 |
At December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Depreciation expense related to property, plant and equipment | ( | ( | ( |
At December 31, | ||||||
(in millions of U.S. dollar) | Consolidated Balance Sheets | 2024 | 2023 | |||
Assets | ||||||
Operating lease right-of-use assets | Property, plant and equipment | |||||
Finance lease assets (A) | Property, plant and equipment | |||||
Total lease assets | ||||||
Liabilities | ||||||
Current: | ||||||
Operating lease liabilities | Trade payables and other | |||||
Finance lease liabilities | Short-term debt | |||||
Non-current: | ||||||
Operating lease liabilities | Trade payables and other | |||||
Finance lease liabilities | Long-term debt | |||||
Total lease liabilities |
At December 31, | ||||||||
(in millions of U.S. dollar) | Consolidated Income Statement | 2024 | 2023 | 2022 | ||||
Operating lease costs (B) | Cost of sales (excluding depreciation and amortization) | ( | ( | ( | ||||
Selling and administrative expenses | ( | ( | ( | |||||
Depreciation related to finance lease | Depreciation and amortization | ( | ( | ( |
At December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Financing cash flows from finance leases | ( | ( | ( | |||
Operating cash flows from operating leases | ( | ( | ( |
At December 31, | ||||
2024 | 2023 | |||
Weighted-average remaining lease term | ||||
Operating leases | ||||
Finance leases | ||||
Weighted-average discount rate | ||||
Operating leases | ||||
Finance leases |
At December 31, 2024 | ||||
(in millions of U.S. dollar) | Operating Leases | Finance Leases | ||
Years ending | ||||
2025 | ||||
2026 | ||||
2027 | ||||
2028 | ||||
2029 | ||||
Thereafter | ||||
Total non-cancelable minimum lease payments | ||||
Less: interest | ( | ( | ||
Present value of lease liabilities |
(in millions of U.S. dollar) | Technology | Computer Software | Customer relationships | Work in Progress | Other | Total Intangible Assets | ||||||
At December 31, 2024 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated amortization | ( | ( | ( | ( | ( | |||||||
Net balance at December 31, 2024 | ||||||||||||
At December 31, 2023 | ||||||||||||
Gross carrying value | ||||||||||||
Less accumulated amortization | ( | ( | ( | ( | ( | |||||||
Net balance, at December 31, 2023 | ||||||||||||
At December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Amortization expense related to intangible assets | ( | ( | ( |
(in millions of US Dollars) | At December 31, 2024 | |
Year ending | ||
2025 | ( | |
2026 | ( | |
2027 | ( | |
2028 | ( | |
2029 | ( |
At December 31, | ||||||||
2024 | 2023 | |||||||
(in millions of U.S. dollar) | Non-current | Current | Non-current | Current | ||||
Trade payables | — | — | ||||||
Employees' entitlements | — | — | ||||||
Contract liabilities and other liabilities to customers | ||||||||
Operating lease liabilities | ||||||||
Other payables | ||||||||
Total other | ||||||||
Total trade payables and other |
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Contract liabilities and other liabilities to customers at January 1, | ||||||
Revenue deferred from contract liabilities | ||||||
Revenue recognized from contract liabilities | ( | ( | ( | |||
Effect of changes in foreign currency rates and other changes | ( | ( | ( | |||
Contract liabilities and other liabilities to customers at December 31, |
At December 31, | ||||||||||
2024 | 2023 | |||||||||
(in millions of U.S. dollar) | Nominal Value in Currency | Nominal rate | Effective rate | Face Value | Debt issuance costs | Accrued interest | Carrying value | Carrying value | ||
Secured Pan-U.S. ABL (due 2029) (A) | $ | Floating | ||||||||
Senior Unsecured Notes | — | — | — | — | ||||||
Issued November 2017 and due 2026 (B) | $ | |||||||||
Issued November 2017 and due 2026 (B) | € | |||||||||
Issued June 2020 and due 2028 | $ | ( | ||||||||
Issued February 2021 and due 2029 | $ | ( | ||||||||
Issued June 2021 and due 2029 | € | ( | ||||||||
Issued August 2024 and due 2032 (C) | $ | ( | ||||||||
Issued August 2024 and due 2032 (C) | € | ( | ||||||||
Finance lease liabilities | ||||||||||
Other loans (D) | ||||||||||
Total debt | ( | |||||||||
Of which non-current | ||||||||||
Of which current (E) |
(in millions of U.S. dollar) | At December 31, 2024 | |
Year ending | ||
2025 | ||
2026 | ||
2027 | ||
2028 | ||
2029 | ||
Thereafter | ||
Total undiscounted cash flows |
At December 31, | ||||||||||||
2024 | 2023 | |||||||||||
(in millions of U.S. dollar) | Non- current | Current | Total | Non- current | Current | Total | ||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Currency net debt derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivatives instruments - assets | ||||||||||||
Derivatives that qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Derivatives that do not qualify for hedge accounting | ||||||||||||
Currency commercial derivatives | ||||||||||||
Energy derivatives | ||||||||||||
Metal derivatives | ||||||||||||
Fair value of derivatives instruments - liabilities |
At December 31, | ||||||||||||||||
2024 | 2023 | |||||||||||||||
(in millions of U.S. dollar) | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||
Fair value of derivatives instruments - assets | ||||||||||||||||
Fair value of derivatives instruments - liabilities |
Sold currencies | Maturity Year | Less than 1 year | Over 1 year | |||
USD | 2025-2029 | |||||
CHF | 2025-2027 | |||||
CZK | 2025 | |||||
Other currencies | 2025-2026 |
Purchased currencies | Maturity Year | Less than 1 year | Over 1 year | |||
USD | 2025-2026 | |||||
CHF | 2025-2028 | |||||
CZK | 2025-2026 | |||||
Other currencies | 2025 |
Year ended December 31, | ||||||||
(in millions of U.S. dollar) | Notes | 2024 | 2023 | 2022 | ||||
Derivatives that do not qualify for hedge accounting | ||||||||
Included in Other gains and losses - net | ||||||||
Realized (losses) / gains on foreign currency derivatives - net (A) | 5 | ( | ( | |||||
Unrealized (losses) / gains on foreign currency derivatives - net (B) | 5 | ( | ( | |||||
Derivatives that qualify for hedge accounting | ||||||||
Included in Other comprehensive income | ||||||||
Unrealized (losses) / gains on foreign currency derivatives - net | ( | ( | ||||||
Gains reclassified from cash flow hedge reserve to the Consolidated Income Statement | ||||||||
Included in Revenue (C) | ||||||||
Realized losses on foreign currency derivatives - net (A) | 5 | ( | ( | ( | ||||
Unrealized (losses) / gains on foreign currency derivatives - net | 5 | ( |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Derivatives that do not qualify for hedge accounting | ||||||
Included in Finance costs - net | ||||||
Realized gains on foreign currency derivatives - net (A) | ||||||
Unrealized (losses) / gains on foreign currency derivatives - net | ( | ( | ||||
Total |
(in millions of U.S. dollar) | Maturity | Less than 1 year | Over 1 year | |||
Metal | 2025-2027 | |||||
Natural gas | 2025-2027 |
Year ended December 31, | ||||||
(in millions of U.S. dollar) | 2024 | 2023 | 2022 | |||
Derivatives that do not qualify for hedge accounting | ||||||
Included in Other gains and losses - net | ||||||
Realized gains / (losses) on commodities derivatives - net (A) | ( | ( | ||||
Unrealized gains / (losses) on commodities derivatives - net | ( |
At December 31, | ||||||||||||
2024 | 2023 | 2022 | ||||||||||
Rate of increase in salaries | Discount rate | Expected return rate (A) | Rate of increase in salaries | Discount rate | Expected return rate (A) | Rate of increase in salaries | Discount rate | Expected return rate (A) | ||||
Pension | ||||||||||||
OPEB | n/a | n/a | n/a |
At December 31, | |||||||
2024 | 2023 | ||||||
(in millions of U.S. dollar) | Pension Benefits | OPEB and Other Benefits | Total | Pension Benefits | OPEB and Other Benefits | Total | |
Present value of funded obligation | |||||||
Fair value of plan assets | ( | ( | ( | ( | |||
Deficit of funded plans | |||||||
Present value of unfunded obligation | |||||||
Net liability arising from defined benefit obligation | |||||||
of which non-current | |||||||
of which current | |||||||
Year ended December 31, | ||||||||
2024 | 2023 | 2022 | ||||||
(in millions of U.S. dollar) | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | Pension | OPEB and Other Benefits | ||
Current service cost | ( | ( | ( | ( | ( | ( | ||
Interest cost | ( | ( | ( | ( | ( | ( | ||
Expected return on plan assets | ||||||||
Immediate recognition of gains arising over the year | ( | |||||||
Amortization of past service (cost) / gain | ||||||||
Amortization of net actuarial (loss) / gain | ( | ( | ( | |||||
Curtailment and settlements | ||||||||
Total net pension and other long-term benefit cost | ( | ( | ( | ( | ( |
Year ended December 31, 2024 | ||||||||||
Defined benefit obligations | Plan assets | Net defined benefit liability | ||||||||
(in millions of U.S. dollar) | Pension benefits | OPEB and Other Benefits | Total | |||||||
At January 1, 2024 | ( | |||||||||
Included in the Consolidated Income Statement | ||||||||||
Current service cost | — | |||||||||
Interest cost / (income) | ( | |||||||||
Immediate recognition of gains arising over the year | — | |||||||||
Included in the Statement of Comprehensive Income | ||||||||||
Remeasurements due to: | ||||||||||
—actual return less interest on plan assets | — | — | — | ( | ( | |||||
—changes in financial assumptions | ( | ( | ( | — | ( | |||||
—changes in demographic assumptions | — | |||||||||
—experience (gains)/ losses | ( | — | ||||||||
Effects of changes in foreign exchange rates | ( | ( | ( | ( | ||||||
Included in the Consolidated Statement of Cash Flows | ||||||||||
Benefits paid | ( | ( | ( | ( | ||||||
Settlement | ( | ( | ||||||||
Contributions by the Group | — | — | — | ( | ( | |||||
Contributions by the plan participants | ( | |||||||||
At December 31, 2024 | ( |
Year ended December 31, 2023 | ||||||||||
Defined benefit obligations | Plan Assets | Net defined benefit liability | ||||||||
(in millions of U.S. dollar) | Pension benefits | OPEB and Other Benefits | Total | |||||||
At January 1, 2023 | ( | |||||||||
Included in the Consolidated Income Statement | ||||||||||
Current service cost | — | |||||||||
Interest cost / (income) | ( | |||||||||
Immediate recognition of gains arising over the year | — | |||||||||
Included in the Statement of Comprehensive Income | ||||||||||
Remeasurements due to: | ||||||||||
—actual return less interest on plan assets | — | — | — | ( | ( | |||||
—changes in financial assumptions | — | |||||||||
—changes in demographic assumptions | — | |||||||||
—experience (gains)/ losses | ( | ( | — | ( | ||||||
Past service cost | ( | ( | — | ( | ||||||
Effects of changes in foreign exchange rates | ( | |||||||||
Included in the Consolidated Statement of Cash Flows | ||||||||||
Benefits paid | ( | ( | ( | ( | ||||||
Contributions by the Group | — | — | — | ( | ( | |||||
Contributions by the plan participants | ( | |||||||||
Disposed of through business combination | ( | ( | ( | ( | ||||||
At December 31, 2023 | ( |
At December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
Cash & cash equivalents | ||||
Equities | ||||
Fixed income | ||||
Property | ||||
Other | ||||
Total fair value of plan assets |
Estimated benefits payments | ||||
(in millions of U.S. dollar) | Pensions | OPEB and Other Benefits | ||
Year ended December 31, | ||||
2025 | ||||
2026 | ||||
2027 | ||||
2028 | ||||
2029 | ||||
2030 to 2034 |
At December 31, | ||||||||
2024 | 2023 | |||||||
(in millions of U.S. dollar) | Current | Non current | Current | Non current | ||||
Close down and environmental remediation costs | ||||||||
Restructuring costs | ||||||||
Legal claims and other costs | ||||||||
Total provisions |
At December 31, | ||||
(in millions of U.S. dollar) | 2024 | 2023 | ||
Litigation | ||||
Disease claims (A) | ||||
Total provisions for legal claims and other costs |
(in millions of U.S. dollar) | ||||||
Number of shares | Ordinary shares | Additional paid in capital | ||||
At January 1, 2024 | ||||||
At December 31, 2024 (A) |
(in millions of U.S. dollar) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive (loss) / income | ||||
At January 1, 2024 | ( | ( | ||||||
Other comprehensive income / (loss) before reclassification | ( | ( | ( | |||||
Amounts reclassified from accumulated other comprehensive loss to the income statement | ( | |||||||
At December 31, 2024 | ( | ( | ( |
(in millions of U.S. dollar) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2023 | ( | ( | ||||||
Other comprehensive income / (loss) before reclassification | ( | ( | ( | |||||
Amounts reclassified from accumulated other comprehensive loss to the income statement | ( | ( | ||||||
Amounts from disposal of entities reclassified to the income statement | ( | ( | ( | |||||
At December 31, 2023 | ( | ( |
(in millions of U.S. dollar) | Post- employment benefit plans | Cash flow hedges | Currency translation adjustments | Accumulated other comprehensive income / (loss) | ||||
At January 1, 2022 | ( | ( | ( | ( | ||||
Other comprehensive income / (loss) before reclassification | ( | |||||||
Amounts reclassified from accumulated other comprehensive loss to the income statement | ( | |||||||
At December 31, 2022 | ( | ( |
2024 PSUs | 2023 PSUs | |||
Fair value at grant date (in dollars) | ||||
Share price at grant date (in dollars) | ||||
Dividend yield | ||||
Expected volatility (A) | ||||
Risk-free interest rate (US government bond yield) | ||||
Model used | Monte Carlo | Monte Carlo |
Performance-Based RSU | Restricted Stock Units | ||||||||
Potential Shares | Weighted-Average Grant-Date Fair Value per Share | Potential Shares | Weighted-Average Grant-Date Fair Value per Share | ||||||
At January 1, 2024 | $ | $ | |||||||
Granted (A) | $ | $ | |||||||
Over-performance (B) | $ | $ | |||||||
Vested | ( | $ | ( | $ | |||||
Forfeited (C) | ( | $ | ( | $ | |||||
At December 31, 2024 | $ | $ |
Name | Age | Position | Date of Appointment | Current Term | ||||
Jean-Christophe Deslarzes | 61 | Chairman | May 11, 2021 | 2024-2027 | ||||
Michiel Brandjes | 70 | Director | June 11, 2014 | 2023-2026 | ||||
John Ormerod | 76 | Director | June 11, 2014 | 2023-2026 | ||||
Lori A. Walker | 67 | Director | June 11, 2014 | 2022-2025 | ||||
Martha Brooks | 65 | Director | June 15, 2016 | 2022-2025 | ||||
Jean-Marc Germain | 59 | Director and also CEO | June 15, 2016 | 2023-2026 | ||||
Isabelle Boccon-Gibod | 56 | Director | May 11, 2021 | 2024-2027 | ||||
Jean-Philippe Puig | 64 | Director | May 11, 2021 | 2024-2027 | ||||
Jean-François Verdier | 61 | Employee Director | December 1, 2021 | 2024-2027 | ||||
Wiebke Weiler | 40 | Employee Director | December 1, 2021 | 2024-2027 | ||||
Emmanuel Blot | 39 | Director | June 10, 2022 | 2022-2025 |
Name | Age | Title | |||
Jean-Marc Germain | 59 | Chief Executive Officer | |||
Ingrid Joerg | 55 | Executive Vice President and Chief Operating Officer President, Packaging & Automotive Rolled Products business unit | |||
Jack Guo | 46 | Senior Vice President and Chief Financial Officer | |||
Philippe Hoffmann | 59 | President, Aerospace & Transportation business unit | |||
Alexandra Bendler | 51 | President, Automotive Structures & Industry business unit | |||
Ludovic Piquier | 52 | Senior Vice President Manufacturing Excellence and Chief Technical Officer | |||
Philip Ryan Jurkovic | 53 | Senior Vice President and Chief Human Resources Officer | |||
Nicolas Brun | 58 | Senior Vice President, Public Affairs, Communications and Sustainability | |||
Marcus Becker | 49 | Senior Vice President & Chief Procurement Officer | |||
Niklaus Schild | 46 | Senior Vice President, Chief Information Officer and Chief Digital Officer | |||
Stephen Walters | 60 | Senior Vice President, Group General Counsel (1) |
Plan Category | Number of securities to be issued upon exercise of outstanding options,warrants and rights (1) (a) | Weighted average exercise price of outstanding options, warrants and rights (b) | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column a) (2)(c) |
Equity compensation plans approved by shareholders | 3,448,644 | N/A | 6,000,000 |
Equity compensation plans not approved by shareholders | N/A | N/A | N/A |
Total | 3,448,644 | N/A | 6,000,000 |
Name of beneficial owner of ordinary shares | Amount and Nature of Beneficial Ownership | As a percentage of the Total Ordinary Shares Outstanding | ||||
5% Shareholders | ||||||
T. Rowe Price Investment Management, Inc. | 19,828,738 | (1) | 13.8% | |||
FMR LLC | 14,643,776 | (2) | 10.2% | |||
Caisse des Dépôts (f/k/a Caisse des Dépôts et Consignations), Bpifrance Participations S.A., Bpifrance S.A. (f/k/a BPI-Groupe), EPIC Bpifrance (f/k/a EPIC BPI-Groupe) | 12,593,903 | (3) | 8.8% | |||
BlackRock, Inc. | 12,439,991 | (4) | 8.7% | |||
Directors | ||||||
Michiel Brandjes | 52,000 | (5) | * | |||
John Ormerod | 32,873 | (6) | * | |||
Lori A. Walker | 35,044 | (7) | * | |||
Martha Brooks | 169,741 | (8) | * | |||
Isabelle Boccon-Gibod | 21,000 | (9) | * | |||
Jean-Christophe Deslarzes | 26,368 | (10) | * | |||
Jean-Philippe Puig | 21,800 | (11) | * | |||
Jean-François Verdier | 41 | (12) | * | |||
Wiebke Weiler | — | (13) | ||||
Emmanuel Blot | — | (14) | ||||
Named Executive Officers | ||||||
Jean-Marc Germain | 1,560,000 | (15) | 1.1% | |||
Jack Guo | 65,925 | (16) | * | |||
Ingrid Joerg | 155,554 | (17) | * | |||
Philippe Hoffmann | 104,288 | (18) | * | |||
Philip Ryan Jurkovic | 129,180 | (19) | * | |||
All executive officers and directors as a group (21 people) | 2,654,137 | (20) | 1.8% |
For the year ended December 31, | ||||
( in thousands of U.S. Dollars) | 2024 | 2023 | ||
Audit fees | 6,738 | 5,040 | ||
Audit-related fees | 253 | 114 | ||
Tax fees | 293 | 316 | ||
All other fees | 5 | 5 | ||
Total(1) | 7,289 | 5,475 |
3.1 | |
4.1 | |
4.2 | |
4.3 | |
4.4 | |
4.5 | |
4.6 | |
4.7 | |
4.8 | |
4.9 | |
10.1 | |
10.2 | |
10.3 | |
10.4 | |
10.5 | |
10.6 | |
10.7 | |
10.8 | |
10.9 | |
10.10 | |
10.11 | |
10.12 | |
10.13 | |
10.14 | |
10.15 | |
10.16 | |
10.17 | |
10.18 | |
10.19 | |
10.20 | |
10.21 | |
10.22 | |
10.23 | |
10.24 | |
10.25 | |
10.26 | |
10.27 | |
10.28 | |
10.29 | |
10.30 | |
10.31 | |
10.32 | |
10.33 | |
10.34 | |
10.35 | |
10.36 | |
10.37 | |
10.38 | |
10.39 | |
10.40 | |
10.41 | |
10.42 | |
10.43 | |
10.44 | |
10.45 | |
10.46 | |
10.47 | |
10.48 | |
10.49 | |
10.50 | |
10.51 | |
10.52 | |
10.53 | |
10.54 | |
10.55 | |
10.56 | |
10.57 | |
10.58 | |
10.59 | |
10.60 | |
10.61 | |
10.62 | |
10.63 | |
10.64 | |
10.65 | |
10.66 | |
10.67 | |
10.68 |
10.69 | |
10.70 | |
10.71 | |
10.72 | |
10.73 | |
10.74 | |
10.75 | |
10.76 | |
10.77 | |
14.1 | |
19.1 | |
21.1 | |
23.1 | |
31.1 | |
31.2 | |
32.1 | |
32.2 | |
97.1 | |
101.INS | Inline XBRL Instance Document** |
101.SCH | Inline XBRL Taxonomy Extension Schema Document** |
101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document** |
101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document** |
101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document** |
101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document** |
104. | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)** |
Constellium SE | ||
Date: February 28, 2025 | By | /s/ Jean-Marc Germain |
Jean-Marc Germain | ||
Chief Executive Officer and Director |
Name | Capacity | Date | ||
/s/ Jean-Marc Germain | Chief Executive Officer and Director | February 28, 2025 | ||
Jean-Marc Germain | (Principal Executive Officer) | |||
/s/ Jack Guo | Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) | February 28, 2025 | ||
Jack Guo | ||||
/s/ Jean-Christophe Deslarzes | Chairman | February 28, 2025 | ||
Jean-Christophe Deslarzes | ||||
/s/ Michiel Brandjes | Director | February 28, 2025 | ||
Michiel Brandjes | ||||
/s/ John Ormerod | Director | February 28, 2025 | ||
John Ormerod | ||||
/s/ Lori A. Walker | Director | February 28, 2025 | ||
Lori A. Walker | ||||
/s/ Martha Brooks | Director | February 28, 2025 | ||
Martha Brooks | ||||
/s/ Isabelle Boccon-Gibod | Director | February 28, 2025 | ||
Isabelle Boccon-Gibod | ||||
/s/ Jean-Philippe Puig | Director | February 28, 2025 | ||
Jean-Philippe Puig | ||||
/s/ Jean-François Verdier | Employee Director | February 28, 2025 | ||
Jean-François Verdier | ||||
/s/ Wiebke Weiler | Employee Director | February 28, 2025 | ||
Wiebke Weiler | ||||
/s/ Emmanuel Blot | Director | February 28, 2025 | ||
Emmanuel Blot | ||||